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USE OF PROBIOTICS TO PREVENT ANTIBIOTIC ASSOCIATED DIARRHEA
Abstract
Antibiotic associated diarrhea (AAD) is defined as the self limiting diarrhea that occurs during or
following a course of antibiotics (Bartlett, 2002; Dendukuri, Costa, McGregor, & Brophy, 2005;
Pimental & Choure, 2009; Sullivan & Nord, 2005; Vrabie & Aberra, 2009). Despite strong
support for the use of probiotics in the outpatient setting for preventing AAD, there is lack of
probiotic utilization by primary care providers in the outpatient setting. Current literature
indicates that one of the barriers to probiotic use is medical doctors’ (MDs) and nurse
practitioners’ (NPs) attitude and lack of knowledge regarding the use of probiotics in preventing
antibiotic associated diarrhea. The purpose of this study was to evaluate the current attitude and
knowledge of providers (MD, NP and physician assistant [PA]) in a primary care practice in
central and eastern Connecticut. Current attitude towards of the use of probiotics to prevent
AAD was positive (p=0.083). The level of providers knowledge increased by 17.53% (p=0.002).
NPs showed a greater increase in knowledge in the post test than MDs (F(21)=59.345, p=0.005).
The second purpose of the study was to introduce an evidence-based protocol, during an
educational intervention, for use in the adult outpatient setting. The third purpose of the study
was to evaluate providers’ use of probiotics as documented in the Electronic Medical Record
after the introduction of an educational intervention. There was a 50% increase in the number of
providers recommending probiotics when prescribing an antibiotic. The result of this study
showed providers have a positive attitude toward the use of probiotics to prevent AAD. There
was also an increase in the provider knowledge of probiotic use after an educational intervention
and the introduction of an evidence-based protocol. There was also an increase in the number of
providers who recorded their recommendation of a probiotic when prescribing an antibiotic.
Educational programs can be successful in introducing any evidence-based protocol. Further
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research is needed to evaluate if this increase in the use of probiotics is sustained. Further
research is also needed to evaluate the extent providers implement the evidence-based protocol
within their practice.
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Problem
Statement of the Problem
Many episodic visits to primary care providers are due to complaints related to an
infective process; cellulitis, sinusitis, community acquired pneumonia, etc. These are
appropriate and reasonable conditions for antibiotic treatment. All antibiotics have the potential
side of effect of diarrhea which puts the patient at risk for antibiotic associated diarrhea (AAD),
this risk is increased if the patient has co-morbidities or advanced age. Preventing AAD
improves patient health outcomes. The current treatment for AAD is to stop the prescribed
antibiotic; evidence supports AAD prevention by adding a probiotic to the treatment regime.
Probiotics have not been used widely or consistently in the adult outpatient setting. One of the
barriers to probiotic use is lack of provider knowledge of probiotics to prevent AAD. The
purpose of this study is to discover what providers attitude and knowledge about probiotics and
if an educational intervention increases probiotic use in the outpatient adult setting.
AAD affects one in five adults prescribed antibiotics (Avadhani & Miley, 2011;
Weichseilbaum, 2009). When a probiotic is taken concurrently with an antibiotic, AAD is
reduced to one in ten adults (Avadhani & Miley, 2011; Weichseilbaum, 2009). Several metaanalyses support the use of probiotics to prevent AAD in the adult population (Avadhani &
Miley, 2011; Cremonini, et al, 2002; D’Souza, Rajkumar, Cooke, & Bulpitt 2002; Kale-Pradhan,
Jassal & Wilhelm 2010; McFarland 2010; Sazawal, et al 2006; Szajewska & Mrukowicz 2005).
Only a few studies specifically describe the use of probiotics in the adult outpatient population
(Armuzzi, et al., 2001). The evidence supports the use of probiotics to prevent AAD in the adult
outpatient population. It is not clear if probiotics are currently used by primary care providers.
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Information discussing provider attitude and knowledge in the use of probiotics to
prevent AAD is minimal. Hermosilla (2009) reports that after an educational session there was
an increase in probiotic prescribing in a medical intensive care unit. Camras (2008) proposed an
educational project to be done at an adult primary care practice however results were not
reported in her paper. Nichols, Grobe and Roche (2005) report on a web based survey they used
to determine what advice general practitioners give to patients regarding probiotics. Nichols, et
al. concludes that greater than 50% of the general practitioners advise probiotics in certain
clinical scenarios.
The main purpose of this study is to evaluate the knowledge and attitude toward the use
of probiotics to prevent AAD. The study evaluated approximately 70 providers (MD, NP, and
PA) in a primary care and urgent care practice located in central and eastern Connecticut. The
secondary purpose is to introduce an evidence-based protocol for the use of probiotics to prevent
AAD accomplished by an in person educational intervention. The final purpose of this study is
to identify if knowledge increases and practice changes following the educational intervention.
Goals of the Project
•

To get at least 50% participation from the 70 providers to complete the study.

•

To design an evidence-based protocol for the use of probiotics to prevent AAD in the
outpatient adult setting.

•

To present an educational intervention introducing the evidence-based protocol to the
provider staff.

•

To document and analyze current antibiotic and probiotic prescribing habits of Primary
Care Providers.
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•

To present results to the medical staff at the conclusion of this project.

Evidence of the Problem
Antibiotics continue to be prescribed in large numbers. According to the American
College of Physicians (2011), 133 million courses of antibiotics are prescribed each year. These
are for wide ranging infections, e.g.: sinusitis, community acquired pneumonia, cellulitis, urinary
tract infections, etc. There is variation of specific antibiotic prescribed, depending on presumed
infective bacteria, co-morbidities, and bacteria sensitivities. The use of any antibiotic for any
infection can cause AAD. This indicates that increasing the number of antibiotics increases the
incidence of AAD.
The incidence of AAD is reported as between 5 -30% of adults prescribed antibiotics
(Avadhani & Miley, 2011; Bartlett, 2002; Hickson, et al, 2007; Jenkins, et al 2005; McFarland,
1998; Pimental & Choure, 2009; Sullivan & Nord, 2005; Teitelbaum & Walker, 2002;
Weichselbaum, 2009). These numbers represent the total incidence of AAD both inpatient and
outpatient. McFarland (2008) states that outpatient incident rates of diarrhea for every 100 visits
for diarrhea 34 are for AAD. Using these reported incidences, approximately 29 million adults in
the United States experienced AAD during a course of outpatient antibiotic treatment in the year
2001. Despite these numbers the true incidence of AAD in the outpatient adult population is
higher; in a study by Gessert & Rubin (2011), they conclude that AAD is underreported.
In the outpatient setting, antibiotic associated gastrointestinal side effects are often the
reason a patient stops the antibiotic, but this information is not regularly reported to the provider
by the patient (Armuzzi, et al, 2001). Anastasio, et al, (1992) report a discontinuance rate for
erythromycin due to diarrhea as between 4%-25%. Damrongmane and Ukarapol (2007) report
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two thirds of the pediatric patients with AAD the antibiotic was stopped without medical advice.
The inpatient setting is a controlled environment; the administration of medications is controlled
by facility practice guidelines, while there is no control in the outpatient setting. In conclusion,
the prevention of the side effect of AAD is averted then the full antibiotic course is likely to be
finished. By inference there would be a decrease in Clostridium difficile cases, as C. difficile is
considered a subset of AAD for the purposes of this study.
A review of the existing literature supports the prophylactic use of probiotics to prevent
AAD in the adult inpatient setting. In the outpatient setting there is the challenge of different
infective processes and different antibiotic treatments. The reviewed studies were not diagnosis
specific nor were they antibiotic specific and most did not control for these variables. This is
helpful in the outpatient setting when the choice of antibiotic is generally broader for the range of
infective processes treated. The support of concurrent probiotic use in a wide variety of
diagnostic and treatment combinations becomes very helpful in the outpatient adult setting
(Armuzzi, et al, 2001; Avadhani & Miley, 2011; Cremonini, et al., 2002; Kale-Pradhan, Jassal &
Wilhelm, 2010; McFarland, 2010; Sazawal, et al, 2006; Szajewska & Mrukowicz, 2005).
Armuzzi, et al., (2001), Avadhani and Miley, (2011), Cremonini, et al., (2002), KalePradhan, Jassal and Wilhelm, (2010), McFarland, (2010), Sazawal, et al., (2006) and Szajewska
and Mrukowics, (2005), all focused on reducing AAD in the inpatient setting, this speaks to a
need for further investigation of the use of probiotics in the outpatient setting. The conclusions
of these meta-analyses are applicable in the outpatient setting for use of probiotics for the
prevention of AAD. These supplements are readily available over the counter and their use in
the outpatient setting is relatively unknown.
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Armuzzi, et al., (2001), is an outpatient adult study that addresses probiotic use for the
prevention of AAD. This study looked at 60 healthy adults who were asymptomatic,
Helicobactor pylori positive in an outpatient setting. Study participants were randomized to
either probiotic or placebo while receiving standard treatment with a macrolide antibiotic; an
antiparasitic and proton pump inhibitor. They used Lactobacillus GG 6 x 109 CFU for 14 days,
in the treatment arm of the study. The probiotic was given the week of H. pylori eradication
therapy and the week after. They report a significant reduction of AAD, (RR=0.1; CI 95% 0.10.9). They conclude that L. GG is effective in reducing the incidence of AAD in the adult
outpatient setting.
It is unclear why there are so few studies of probiotics for the prevention of AAD in the
adult outpatient setting. The researcher proposes that probiotics are over the counter
supplements sold direct to consumer and monetary allocation for these types of studies may not
benefit the companies. Studies that look at provider attitude and knowledge would direct
educational programs to increase awareness of the benefits of probiotics. For probiotics to be
considered evidence based practice these studies need to be done to provide support for their use.
Community Needs Assessment
In a demonstration project started in 2007, the medical team of a rural eastern
Connecticut skilled nursing facility (SNF) noted an increase in the incidence of diarrhea. This
prompted a review to determine the root cause of this increase. Increases in antibiotic usage, due
to an outbreak of upper respiratory infection, lead to these cases of AAD. It was felt that there
must be a way to treat or prevent diarrhea associated with antibiotics. The protocol shows a
reduction in AAD to zero over a five year time frame. This protocol consists of the
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administration of a probiotic every time a course of antibiotics is prescribed. The protocol
continues to be in place at this SNF.
If the introduction of a probiotic can reduce AAD in the SNF population can the same
reduction be realized in the outpatient adult setting? It is well documented that probiotics are
effective in reducing the incidence of AAD in the pediatric outpatient setting but there is little
documentation supporting the use of probiotics for adults. This gap in the literature provides an
opportunity for research.
Several personal discussions were undertaken with specialists within the researchers’
provider community. In a discussion on November 9, 2011 the local infectious disease
specialist, Eugene M. Ciccone, MD, agrees that there is a need for the use of probiotics in adults
and further study is need in the outpatient adult setting. Ajit J. Kokkat, MD, a local
gastroenterologist, also supports the use of probiotics in the adult population and agrees that
there is a need for further study in the population. Dr. Kokkat reviewed and endorsed the
proposed protocol. The information was also reviewed by Lynn M. Rapsilber, MSN, APN-BC,
APRN, specializes in gastroenterology; is an advocate of the use of probiotics to prevent AAD.
Ms. Rapsilber also reviewed and endorsed the protocol. This project was formally approved by
Kent Stahl, MD, Chief Executive Officer and Medical Director of Hartford Medical Group. A
formal stakeholder letter can be found in Appendix 4. As the medical director, Dr Stahl is
supportive of the need for research within the adult population. This study has also been
discussed and approved by the office medical director, Michael A. Kilgannon, MD.
Stakeholders

13

USE OF PROBIOTICS TO PREVENT ANTIBIOTIC ASSOCIATED DIARRHEA
Key stakeholders include the decision makers Hartford Medical Group (HMG). These
decision makers include the Chief Executive Officer/Chief Medical Officer, Kent Stahl, MD and
the Chief Operating Officer, John Fundock, PA. They supported the provided time during the
medical staff meeting for the educational intervention.
Review of Literature
Antibiotic associated diarrhea is accepted to refer to the diarrhea that occurs during or
following a course of antibiotics (Bartlett, 2002; Dendukuri, et al, 2005; Pimental & Choure,
2009; , Sullivan & Nord, 2005; Vrabie & Aberra, 2009).The incidence of AAD is reported as
between 5 -30% (Bartlett, 2002; Hickson, et al, 2007; Pimental & Choure, 2009; Sullivan &
Nord, 2005; Teitelbaum & Walker, 2002). Bartlett (2002) breaks down these percentages by
offending antibiotic: ampicillin, 10-25%; amoxicillin-clavulanate, 10-25%; cefixime, 15-20%;
and all others cephalosporins, fluoroquinolones, azithromycin, clarithromycin, erythromycin, and
tetracycline, 2-5%. Jenkins, et al (2005) report 30% of patient can experience AAD. For the
purposes of this study C. difficile is considered a subset of AAD.
Diarrhea can pose a serious problem for any patient beyond the nuisance factor. Diarrhea
leading to dehydration and electrolyte imbalance complicates the treatment of a simple infection.
Add this to any potential co-morbid conditions a patient may have and a life threatening situation
can ensue. The prevention of all types of diarrhea associated with antibiotic use would decrease
negative outcomes, avoid adverse events, save healthcare dollars and decrease the likelihood of
the patient stopping the antibiotic therapy prematurely due to diarrhea. The use of narcotics and
antidiarrheal medications combined with the derangement of the intestinal flora has been
postulated to potentially cause the complication of toxic mega-colon. In the outpatient setting
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preventing diarrhea means a course of antibiotics is completed as directed, as well as both direct
and indirect healthcare costs are reduced. The current approach to AAD is to discontinue the
offending antibiotic (Bartlett, 2002).
It is generally accepted that the cause of AAD is exposure to antibiotics, oral or
parenteral (Bartlett, 2002; Rohde, Bartolini & Jones, 2009; Vogel, 1995; Vrabie & Aberra,
2009). Other risk factors include: use of fluoroquinolones, neonates born prematurely, severe
illness, prolonged antibiotics use, nasogastric intubation, age greater than 65 years, male gender,
use of proton pump inhibitor, medical patient, increased length of hospital stay, gastrointestinal
surgery or gastrointestinal manipulation, immunodeficiency, narcotic use and antidiarrheal
medications (Bartlett, 2002; Rohde, Bartolini & Jones, 2009; Vogel, 1995; Vrabie & Aberra,
2009).
There are currently no clinical guidelines for the use of probiotics in the outpatient
setting. A search of the National Guideline Clearinghouse, the Cochrane Library, Pub Med, and
CIAHL, from 1980 to present, yielded evidence and suggestion of probiotic use but no
guidelines that outline safety, dosing, adverse events and recommended protocols. A search
using the term antibiotic associated diarrhea in the National Guideline Clearinghouse returned 61
possible guidelines but none were specific for AAD. The closest guideline; “World
Gastroenterology Organisation (WGO) practice guideline: acute diarrhea,” however, this
guideline does not address diarrhea specifically associated with antibiotics. It does address the
use of probiotics: “Controlled clinical intervention studies and meta-analyses support the use of
the specific probiotic strains and products in the treatment and prevention of rotavirus diarrhea in
infants. However, all effects are strain-specific and need to be verified for each strain in human
studies. Extrapolation from the results of even closely related strains is not possible, and
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significantly different effects have been reported” (WGO, 2008, page 9). A search of the
Cochrane Library found 29 citations with the search antibiotic associated diarrhea. Two of these
were considered applicable to this paper. One entitled “Probiotics for the prevention of pediatric
antibiotic-associated diarrhea” is a full review with recommendations (Johnston, Supina, Ospina,
& Vohra, 2007). This report is specific for the pediatric population and has limited applicability
to the adult population. The other report, “Probiotics for the prevention of Clostridium difficile
antibiotic-associated diarrhea in adults and children,” is only in the development stage with no
standards put forth at this time (Pillai & Nelson, 2008).
Antibiotic Associated Diarrhea
Probiotics have a role in the prevention of AAD. A probiotic is defined by the World
Health Organization as “Live microorganisms which when administered in adequate amounts
confer a health benefit on the host,” (Weizman, Asli & Alsheikh, 2005; World Health
Organization, 2001, page 5). The Cochrane Collaboration has approved a review that states
probiotic treatment was demonstrated to be beneficial versus placebo in the prevention of
pediatric AAD (Johnson, et al, 2008). The literature discussing prevention of AAD in the adult
population using probiotics has many small studies that make comparisons between the studies
challenging (Armuzzi, et al, 2001; Davidson, Hibberd, Calderwood, & Baron, 2009; Dendukuri,
et al, 2005; Sullivan & Nord, 2005). Acknowledging current studies are disparate there is
evidence for the use of probiotic monotherapy to prevent AAD in adults in the inpatient setting
(D’Sousza, Rajkumar, Cooke & Bulpitt, 2002; Santosa, Farnworth & Jones, 2006; Sullivan &
Nord, 2005). In a randomized control study (RCT) by Hickson, et al, (2007) researchers gave
inpatients a probiotic drink that contained three different probiotics which showed a significant
reduction in the incidence of AAD (p=0.007). Wallace (2009) notes that a dose dependent effect
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improved outcomes of AAD when the dose was 5.5 to 20 billion colony forming unit (CFU) per
day. Of the 10 studies evaluated by Wallace, five studies looked at monotherapy using
Lactobacillus sporogenes, Lactobacillus GG or Saccharomyces boulardii and all decreased the
incidence of AAD. None of the studies were able to agree on which probiotic to use, dose of
probiotic and length of use (D’Sousza, et al, 2002; Dendukuri, et al, 2005; Miller & Fraser,
2009). Accumulated evidence states that probiotics reduce the risk of AAD particularly the
probiotics S. boulardii and L. GG (Wallace, 2009; Weichseilbaum, 2009). Avadhani and
Miley’s (2011) meta-analysis concludes that probiotics provide a relative risk reduction of 44%
for AAD.
The following is a review of the seven meta-analyses found during literature search.
These meta-analyses focus on the adult inpatient population although some did include the
pediatric inpatient and outpatient population. There is one RCT on AAD in the outpatient adult
population, this study is also described.
Avadhani and Miley’s (2011) meta-analysis includes eight RCT evaluating probiotic
efficacies in the prevention of AAD. They include two studies that report negative results with
respect to the use of probiotics in preventing AAD. The perspective of this meta-analysis is
prevention of AAD and C. difficile-associated diarrhea (CDAD) in hospitalized adults. This
review paper focused on their results for AAD. All eight of the articles include results for AAD.
A random effects model in the MAStARI software and the Mantel-Haenszel relative risk ratio
was used to analyze the eight studies. The Forest Plot showed an overall favoring of probiotics
in the prevention of AAD. They report an overall Z=4.75 with a p ≤ 0.001. The relative risk
ratio was 0.56 (95% CI, 0.44-0.71). They do report heterogeneity as being low to moderate
(29.12) owing to the fact that two studies had negative results. No funnel plot was reported.
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They conclude concurrent use of probiotics was effective in preventing AAD in the adult
hospitalized patient.
Cremonini, et al, (2002) review seven RCT for their meta-analysis and report an age
range of two weeks to elderly age groups. This analysis also includes a study with negative
results; it is the same study that is reported as negative in the previous meta-analysis. This
review does not stratify the studies evaluated for setting; this information was extracted from the
discussion and the studies themselves when available. These authors investigated probiotic
monotherapy to prevent AAD. There were two different probiotics represented in this analysis:
Lactobacillus GG and S. boulardii. The Forest Plot showed an overall favoring of probiotics in
the prevention of AAD. This data was analyzed using STATA Software version 6.0 from Texas
University. An overall Z score was not reported. The test for homogeneity gave X2 = 6.001; df =
6; p = 0.42. Mantel-Haenszel was used to calculate the combined relative risk reported as 0.3966
(95% CI, 0.275-0.571). This study reported a funnel plot with no asymmetry observed. These
authors conclude probiotics reduce the risk of AAD.
D’Souza, Rajkumar, Cooke, & Bulpitt (2002) present a meta-analysis that evaluated the
efficacy of probiotics in the prevention and treatment of AAD. This analysis included pediatrics
and adults, two of the studies report pediatric results. This meta-analysis utilized the QUOROM
statement. The outcome measure is the percentage of patients in either arm of the study without
diarrhea. They also performed three separate analyses split by probiotics type: S. boulardii and
lactobacilli or enterococci. A pooled analysis of all nine studies is also included in the
discussion. The Mantel-Haenszel method is applied to determine the benefit of treatment versus
placebo. No publication bias is shown in the funnel plot. The relative risk for all nine studies is
reported as 0.37 (95% CI; 0.26 – 0.53). Homogeneity for all nine trials is p = 0.246. The Forest
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plot favors probiotics preventing AAD. This meta-analysis concluded there is evidence that
probiotics provide protection against AAD. These authors state that probiotics prevent AAD but
it does not treat AAD.
Kale-Pradhan, Jassal & Wilhelm (2010) performed a meta-analysis of Lactobacillus in
both pediatric and adult patients. They looked at Lactobacillus as monotherapy for the
prevention of AAD. They analyzed ten RCT but this paper focused on the results for the adults,
which are reported separately. The risk reduction for the adults is reported as 0.24 (95% CI, 0.08
– 0.75) using Mantel-Haenszel calculation. Heterogeneity was well controlled Tau2 = 1.41; Chi2
= 30.19; df = 5 (p< 0.0001), I2 = 83%. The overall Z score was reported as 2.46 (p = 0.01). A
Forest plot showed Lactobacillus does prevent AAD in adults. They reported a potential
publication bias as the funnel plot graph is asymmetric owing to one of the adult studies had a
very small n. They also report the dose of Lactobacillus ranges from 2 x 109 – 4 x 1010 colony
forming units (CFU). It is of interest to note that the pediatric arm of this meta-analysis did not
reach statistical significance. This study concludes that Lactobacillus monotherapy prevented
AAD in the adult population.
McFarland (2010) presents a systematic review and meta-analysis of S. boulardii in adult
patients. McFarland looked at multiple disease states but this paper concentrated on the metaanalysis for AAD contained in her review. The author reported on ten RCT in adults using S.
boulardii as monotherapy. The Forest plot favors S. boulardii as preventing AAD. This analysis
showed a pooled relative risk of 0.47 (95% CI, 0.35 - 0.63, p < 0.001). The author reported that
heterogeneity was well controlled X2 = 10.8, p = 0.29. The author also reported no publication
bias was found either in Begg’s test (p = 0.93) or the funnel plot. The investigator also reported
that the number needed to treat with S. boulardii to prevent on case of AAD was 10.2. An
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overall Z score was not reported. This study reported that the use of S. boulardii monotherapy is
effective in preventing AAD. This was pooled data of both inpatient and outpatient so no
specific conclusion can be drawn regarding adult outpatient data.
Sazawal, et al (2006) performed a meta-analysis that evaluated the use of probiotics in all
types of acute diarrhea; AAD was a subset that was reported separately. The inclusion criteria
for this analysis looked at RCT that were masked and placebo controlled. For inclusion the
study design is an experimental arm and a control arm that “differed only by the provision of a
probiotic and in which the risk of acute diarrhea in each arm was presented,” (Sazawal, et al,
2006, p. 374). Articles published in both English and French were considered for inclusion by
the authors. They reported on 16 articles that yielded 19 separate AAD studies, one of the
articles had two arms and another had three arms to the study. Ten of the articles focused on
adults and six on children. The risk reduction was reported as 52% (95% CI, 0.35 – 0.65) with a
p = 0.001, for all ages. Heterogeneity test was reported as I2 = 53% (95% CI, 40-68). The Forest
Plot is not reported for AAD. Overall, probiotics were shown to have a protective effect. When
community is the setting probiotics were still shown favorably but not as strong as the overall
effect 0.94 (95% CI, 0.87 – 1.02). The pooled n of the community is 1927; adults and children
cannot be teased out since one of the community studies did not report the age groups separately.
This study also reports a number needed to treat as being for every four adults receiving
probiotics one will have acute diarrhea prevented. This study correctly comments that very few
trials have been carried out in the community regarding probiotics and the prevention of
diarrhea. Those that have been done looked at travelers’ diarrhea or infectious diarrhea, none in
this analysis focused on AAD. These authors found that effect size of probiotic prevention of
AAD type was the highest compared to all other types of acute diarrhea.
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Szajewska & Mrukowicz (2005) analyzed five RCT that evaluated S. boulardii for the
prevention of AAD. They used STATSDIRECT software and QUOROM standards to analyze
the data. The total n is 1076. They reported a risk ratio of 0.43 (95% CI, 0.23-0.78). This
analysis included both children and adults. Unfortunately, the age groups are not reported
separately. The Forest Plot does favor the use of probiotics to prevent AAD. By excluding one
of the trials they were able to achieve homogeneity (X2 =2.9; p = 0.4) and maintain significance,
0.33 (95% CI, 0.22-0.5). They report no publication bias or small sample bias. This analysis
reported on five studies and was the smallest of the meta-analyses. They report the number
needed to treat to prevent AAD is ten. This analysis supports the conclusion that S. boulardii
reduces the risk of AAD.
Armuzzi, et al. (2001) report on a RCT in which they gave outpatient adults probiotics
during a specific antibiotic treatment. The investigators randomized sixty healthy asymptomatic
Helicobactor pylori positive adults to probiotic and placebo. They used a preparation of
Lactobacillus GG (6 x 109 CFU) for 14 days; during the week of treatment and the week after
treatment. The treatment was seven days of raberprazole 20 mg twice a day, clarithromycin 500
mg twice a day and tinidazole 500 mg twice a day. The probiotic was given twice a day one and
half hours after the administration of the antibiotic. Of all of the side effects of antibiotic use
included in the study only diarrhea is significant between the two groups (p=0.026). They
reported a difference in diarrhea rates: placebo being 26.6% versus probiotic 3.3% during the
treatment week. During week two the placebo group had 10% diarrhea and the probiotic group
3.3% diarrhea. The diarrhea was self reported as mild for all participants, which in the context of
the study is defined as ‘observed by could be disregarded’. It should also be noted that the study
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participants were all medical personal (physicians, nurses, biologists, or administrators). This
study shows that probiotics are effective in reducing AAD in the outpatient adult population.
In summary, the seven meta-analyses and one RCT all report a reduction of diarrhea
when probiotics are used to prevent AAD. They all agree that several different probiotics are
safe to use in a wide variety of diagnoses, antibiotics, patient populations and settings. What is
lacking are studies done in the adult outpatient population. The limitations of these analyses are
there is overlap of the studies contained across the meta-analysis, there is no agreement on which
probiotic is the most efficacious, and there is no agreement on dose.
Prescriber Attitude, Knowledge and Habits
There is no research regarding what is current practice in the primary care setting of
probiotic prescribing, in the United States. This may be related to provider lack of education of
efficacy and safety of probiotics. This may also be related to provider attitude to alternative
medication use. The next section illustrates prescriber attitude and knowledge of probiotic use.
Hermosilla (2009) looked at attitude and knowledge of prescribers towards probiotics in
an intensive care setting. The author found that an educational offering increased both physician
(MD) and nurse knowledge and attitudes. However, in the large intensive care setting staff was
not stable and the effect did not appear to be sustained. The prescriber group consisted of MDs
only. The author reports a two fold increase in probiotic prescriptions after the educational
offering. Pre-education session showed 2% (n=2) of the patients receiving antibiotics were
prescribed a probiotic. After the educational session 5% (n=4) were prescribed a probiotic.
While this is an increase in the prescribing of probiotics it is a small increase, Hermosilla (2009)
reports a p value of 0.003.
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Nichols, Grob, and Roche (2005) sent a web-based questionnaire to outpatient primary
care providers in Surrey, England. They reported a 16.6% response rate (n=99). Of the
responders, they found 54% of providers have advised patients on the value of taking probiotics.
Seventy-three percent reported they believed probiotics reduce the incidence of diarrhea. This
study was not specific to AAD.
In summary, these findings show a lack of comprehensive information describing
provider attitude, knowledge and prescribing habits toward probiotics, the studies emphasize the
importance of educating providers on the pathophysiology, efficacy and safety of probiotics in
the prevention of AAD.
Theoretical Framework
The Stetler Model of Research Utilization to Facilitate Evidence-Based practice was used
to frame this study (Gawlinski & Rutledge, 2008; Snyder, Facchiano, & Brewer, 2011; Stetler,
2001). This model supports implementation of practice changes at both the individual and the
organizational levels (Gawlinski & Rutledge, 2008; Stetler, 2001). Stetler (2001, p. 274) states
in her first assumption that the “formal organization may or may not be involved in an
individual’s utilization of research.” This model is also well suited to the provider who has the
ability to evaluate knowledge within their own field of expertise and to evaluate if that evidence
supports a practice change (Snyder, Facchiano, & Brewer, 2011). At this time the primary care
practice, where the implementation occurred, has no formal process for the integration of
evidence-based practice (EBP). However, they do have an organizational roadmap for defining
initiatives using five pillars: service excellence, quality, people, growth, and financial strength.
The integration of EBP supports the quality pillar of the balanced scorecard. The quality pillar is
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defined as “insuring that an infrastructure is in place to drive clinical and service excellence.”
The implementation of EBP would not only support clinical excellence within this pillar it would
provide a process for the implementation of future EBP projects.
Stetler’s (2001) model has five phases: preparation, validation, comparative
evaluation/decision making, translation/application, and evaluation. The following describes the
use of Stetler’s model in this project. The preparation phase was started as part of a
demonstration project at a local SNF, using frail elderly patients. This project leads to inquiring
if the same outcomes could be applied in the outpatient adult setting. The literature review done
for the proposed study focused on meta-analyses, accepted as Level I evidence. As indicated
earlier there are no published evidence-based practice guidelines available. Based on an analysis
of the studies reviewed a practice protocol can be recommended. A randomized controlled trial
was part of the literature review as it best matched the population and setting of the proposed
study. The researcher chose to use meta-analysis as the basis of the literature review as the key
stakeholder is a MD who values Level 1 evidence. The use of Level 1 evidence provides a
strong support for the proposed educational intervention.
Phase II, Validation, was done as a critique of the meta-analyses and one RCT; these
showed that the findings were supportive of the use of probiotics in preventing AAD. A
conclusion of the literature review found several areas that needed to be specified in the present
study such as provider attitude and knowledge toward the use of probiotics to prevent AAD. In
an unpublished study of a quality improvement project done in a long term care facility, the
implementation of concurrent use of antibiotics and probiotics has reduced the incidence of AAD
in this population to zero. This project was developed in response to an increase of diarrhea in
the facility population. A literature review was done and a protocol was presented to the medical
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staff for approval. After approval by the medical staff it was implemented. After approximately
18 months the protocol was reviewed, a cost analysis was performed and the protocol was
streamlined. This protocol continues to be successfully used at the facility. The above issues
impact on the practice utilization as described in Snyder, Facchiano, & Brewer (2011).
Comparative evaluation and decision making, Phase III, requires the synthesized
information found in Phase II be applicable to the practice setting for a change in practice. The
meta-analyses reviewed support the use of prophylactic probiotic use. There are barriers to the
applicability of this information in the current practice setting. These barriers include provider
attitude and knowledge. The proposed study has a good fit in the outpatient setting. The
research study is feasible to complete in the proposed setting, substantiates the current evidence
and impact to current practice.
Phase IV, translation and application, provided an insight into what the current state of
practice and what barriers must be overcome for full application. The proposed study offered
insight into the number of probiotics currently being recommended and this is correlated with the
same provider groups’ knowledge and attitude towards the use of probiotics.
Evaluation, Phase V of Stetlers’ model was done when the data is collected and analyzed
from the study. Refinements were made in the proposed probiotics protocol. Further research is
suggested from the data analysis of the three different purposes of the study.
Project Plan
Project Design
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This project design used two different methods. The first design was a description of the
current use of probiotics in a large corporate primary care and urgent care practice group. The
second project design was a pre and post test of probiotic knowledge and attitude of provider.
These surveys were given before and after an educational intervention presenting a literature
review supporting the use of probiotics to prevent AAD.
The descriptive project looked at the number of antibiotics and probiotics prescribed by
this group at two points in time. The choosing of the time frame is arbitrary. This group of
providers uses the Allscripts® electronic medical record which includes the recording of
prescribed medications. A random week one month prior to the educational intervention was
selected; a data report asked how many antibiotics have been prescribed during a seven day time
frame. There was no restriction on the drug class of antibiotic or infective process. It was
presumed that all prescribed antibiotics are appropriate to the infective process. This descriptive
number was then paired with the descriptive number of how many probiotics were prescribed
during this same seven day time frame. This data was analyzed by provider, MD, NP, and PA.
This data provided information on the prescribing habits of primary care providers without
intrusion by the researcher. This information is valuable in that are few reports of primary care
prescribing habits with descriptive statistics. The disadvantage of this study design is the
inability to provide generalization to any other group.
A pre and post test design utilizing a convenience sample of primary care providers who
prescribe antibiotics was used. The inclusion criterion was all providers; MDs, NPs and PAs
working at the same large practice group as described above. An email was sent to all providers
in the group introducing them to the project. Basic demographic information including names
were obtained. Only the researcher has access to the names of participants. The provider names

26

USE OF PROBIOTICS TO PREVENT ANTIBIOTIC ASSOCIATED DIARRHEA
were converted to a numeric label during data entry. The participant label was used to compare
the pre and post test results for an individual.
The pre-intervention survey was provided before the educational intervention was
presented. The intervention is a power point presentation discussing evidence recommending the
use of probiotics in the prevention of AAD (see Appendix 1 for the protocol and Appendix 7 for
the educational intervention). A post intervention survey was provided just after the educational
intervention presentation. It is understood that this design might have an effect on the
prescribing habits of those who participate by virtue of presenting the information. It is
unknown if the effect is long lasting.
The information was requested from the IT department. A random week in February
2012 was chosen. This represented approximately one month prior to the start of the educational
intervention. The second data run was requested a week after the last educational intervention.
The original plan was to wait a month after all interventions were completed but time constraints
did not allow for the time to wait. The data came in an excel spreadsheet. The data was coded
and loaded into IBM SPSS Statistics 20 software.
The second part of the study was an educational intervention with a pre and post test
questionnaire. This was originally to be done at a staff meeting where all of the providers would
be in attendance. Unfortunately, due to scheduling and time constraints this was not possible.
Instead the educational intervention was provided at the individual provider offices in small
groups. The presentation was kept consistent and providers were able to ask questions. The
providers were assigned a number and all information was entered into the IBM SPSS Statistics
20 software system on the day it was obtained.
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Sample
The study subjects were the 70 providers at a large multi-site primary care group. These
providers consist of MDs, NPs and PAs. The MDs are both family practice and internal
medicine specialties. The NPs are both adult and family specialties. The PAs also practice in
primary care and urgent care specialties. With a sample size of n=70, small effect size (0.3)
determined by Cohen’s convention, and a=0.05, the study has a minimum power of 0.6967 when
using Lenth’s website for calculation for a paired t-test (Lenth, 2006-9). Using the same sample
size, alpha, and small effect size determined by Cohen’s convention when using a table cited in
Munro, (2005).
The original sample was 70 providers, MD, NP, and PA. These providers are a part of a
large multi-site primary care group. The group is located in central and eastern Connecticut.
The data received from the IT department revealed 71 providers had prescribed antibiotics in the
selected week prior to the educational intervention. When the data was received from the IT
department after all of the educational interventions were complete there were 73 providers who
had prescribed antibiotics. Of the providers who prescribed antibiotics 27 completed the project.
This represents only 37.5% of the available providers. This was significantly below the project
goal of 50%. The greatest percentage of participants were the MDs at 15 participants, then the
NPs at 8 participants and finally the PAs at 4 participants, please see Table 1.
Project Site
These providers are part of a large multi-site corporate practice consisting of both
primary care and urgent care. The researcher is a provider at one of the primary care sites.
These offices are located in central and eastern Connecticut. The researcher is affiliated with one
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of the offices located in eastern Connecticut. This provider group is affiliated with a tertiary
acute care center as part of an Accountable Care Organization (ACO). They serve a diverse
population of patients, within urban, suburban and rural areas. They accept all major
commercial insurance plans and Medicare but they do not accept new patients with Medicaid.
This practice group is being used as a convenience to the researcher; as she has access to the
providers and the data. There is a corporate culture of innovation and the CEO is supportive of
this clinical research project. The formal letter of support from Dr. Kent Stahl is found in
Appendix 4. Currently it is unknown as to how many antibiotics are prescribed and how many
probiotics are being recommended in this provider group.
Educational Intervention
This project presented an evidence based protocol abstracted from the current literature
review. This protocol, found in Appendix 1, was developed by the researcher. The protocol was
sent to the local Gastroenterologist, an APRN with a specialty in Gastroenterology and Infectious
Disease specialist for review. These providers gave feedback to the protocol and it was
incorporated into the final protocol. The protocol was introduced to the providers during the
educational intervention. The educational intervention consisted of:
•

a review of translational research

•

a review of AAD,

•

gut pathophysiology,

•

antibiotic disturbance of gut flora,

•

overview of current literature

•

presentation of the proposed protocol found in Appendix 1.
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The education intervention consisted of a PowerPoint presentation describing several
meta-analyses and randomized control trials supporting the use of probiotics for the prevention
of AAD. The PowerPoint presentation can be found in Appendix 7. A protocol for the use of
the probiotics in the outpatient adult setting was presented and discussed during the intervention.
The providers attending were given a copy of the protocol, see Appendix 1. The providers were
also given a handout for patients explaining probiotic use, see Appendix 5. There was positive
feedback related to both the information presented and the handouts. Providers were encouraged
to implement the protocol. The interventions went very well, the MDs were respectful. The
researcher was not made to feel that the information was not valuable because of my professional
title.
Instruments
Prior to the intervention a questionnaire was used to evaluate the office provider’s
attitude and knowledge of probiotics use. The questionnaire that was used was developed and
tested by Nichols, Grob and Roche (2005), there is no identifying name for the questionnaire.
They developed the questionnaire, which consists of 20 items, to look at multiple reasons for
using probiotics. For the purposes of this study only the first four questions were used as a pre
and post test for this project. The original questions developed and used by Nichols, Grob, and
Roche (2009) is reproduced below. The first 4 questions and the last 7 questions are yes or no
answers. The middle 6 questions responses are never, occasionally or frequently.
Nichols, Grob and Roche Provider Probiotic Questionnaire (2009):
Please answer yes or no for the following questions:
1.

Which of the following apply to your advice to patient regarding probiotics:
A.
I know of no reason to advise patients to take probiotics
B.
Probiotic usage may be valid but I have not advised patients on this
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C.
I have advised patients on the value of probiotics
2. Probiotics decrease the incidence of diarrhea
3. Probiotics decrease the risk of thrush
Some of us are ‘trigger happy’ when it comes to prescribing antibiotics, but there is also
the danger of failing to prescribe an antibiotic when an antibiotic is genuinely needed.
Assuming you decide than an antibiotic is necessary, in which of these conditions have
you advised a patient to take a probiotic with and/or after the course of antibiotics?
Please answer never, occasionally, or frequently for the following questions:
4. Probiotics give a boost to host immunity
5. Children with acute suppurative otitis media
6. Health young patients with acute bronchitis
7. Elderly patients with pneumonia
8. Recurrent acute cystitis
9. Severe painful dental abscess
10. Diverticulitis with pyrexia
Other conditions have been found to respond to probiotics to a greater or lesser degree
and probiotics have been suggested as part of a preventive strategy for some conditions.
Have you advised patients to take probiotics for any of the following? Please answer yes
or no for the following questions:
11. Severe eczema
12. Recurrent vaginal thrush
13. Crohn’s disease
14. Ulcerative colitis
15. To reduce the risk of bladder and bowel cancer
16. To reduce the risk of coronary artery disease
17. An infant recovering from viral gastroenteritis
Questions five through seventeen do not pertain to the proposed research project and therefore
was not used for this project. The proposed questionnaire is attached in Appendix 2.
Permission was received from Dr. John Nichols and his co-author Dr. Paul Grob to use
the questionnaire they developed (Nichols, Grob and Roche, 2009). Permission was granted in
the form of an email dated August 10, 2011, see Appendix 6. The original questionnaire was
designed to look at many other disease processes that probiotics may be helpful. As stated above
only the first four questions pertained to this project. Question three was changed due to
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terminology confusion between the United States and England. They used the term “thrush”
meaning a vaginal yeast infection. The term “thrush” was changed for the purposes of this
project. This project used the statement: “vaginitis due to yeast.” Thrush has a different
connotation for United States providers.
Procedure
Institutional Review Board (IRB) approval was obtained from University of
Massachusetts after a lengthy process. My protocol was approved March 1, 2012. This set my
project timeline back by eight weeks as data collection had been slated to start the beginning of
January. Formal approval from Dr. Kent Stahl was obtained on February 13, 2012, see
Appendix 4. The project was introduced at the March Medical Directors meeting by Dr. Kent
Stahl. An email was sent to the providers introducing the research project. The initial email
included an overview of the research project and what participation requires. The email
addresses of the providers were obtained from the shared email group of which the researcher is
a part. An email was sent to all 71 providers to introduce the project. This email consisted of an
outline of the project as well as the IRB information. A separate email was sent to all of the
medical directors requesting to be included in a staff meeting for the purposes of presenting my
educational intervention.
The educational intervention was accomplished by visiting individual office provider
groups and presenting at their monthly provider staff meeting. Six offices were visited between
the March 14, 2012 and April 15, 2012. This was an average of 4.5 providers at each
presentation. One office had only one provider available and the others had four or five
providers available. I was also able to capture three more providers after a meeting for the NPs
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and PAs. A summary of the demographics of the providers who participated is found in Tables
1-4.
Data Collection
The first of data collection for this project was a data set from Electronic Medical Record
(EMR) regarding the current probiotic prescribing habits of providers before and after the
intervention of the educational program. The data requested was limited to adults, 18 years and
older. An arbitrary week was selected prior to the educational intervention. February 5-11, 2012
A second arbitrary week was selected after the educational intervention, April 22-28, 2012. This
was accomplished by filling out an “Analytics Report Request,” a reproduction of this form is
found in Appendix 3. The form was submitted to the IT team. The data set parameters that were
requested from the Information Technology (IT) team: the total number of antibiotics prescribed
and total number of probiotics prescribed during that week for all patients older than 28 years,
any provider, any antibiotic, any probiotic, any diagnosis. Since the data is to determine
provider prescribing habits no patient identifier or patient demographics were requested. The
same process was used for both weeks that the data set was requested.
The EMR used by the providers in the study was Allscripts®. This EMR can record both
medications requiring prescriptions as well as over the counter medications. This information is
stored in the medications section of the EMR and is to be reconciled at every visit.
Reconciliation is the means by which the provider determines that the current list of medications
is accurate. One of the drawbacks of this study is that there is no way of knowing why the
probiotic is not documented in the EMR; not prescribed or not documented. Whether the patient
actually follows through with taking the probiotic is outside the scope of this study.
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Prior to the educational intervention the providers filled out a one page survey that
included both the demographics and the short questionnaire. The questionnaire consisted of
demographic data and four questions. The four questions are listed in Appendix 2. The
demographics included:
•

Name (which is only used for matching the tests)

•

Provider type: MD, NP, or PA

•

Gender: Male or Female

•

Age: 20-29, 30-39, 40-49, 50-59, 60-69, 70 or older

•

Educational level: certificate, masters, MD or PhD

The surveys from each provider were entered into an IBM SPSS Statistics 20 software
database for analysis.
Data Analysis
The analysis of the information collected from the Allscripts® EMR regarding current
prescribing habits was done with descriptive statistics. This provides a snapshot of current
clinical practice of the providers in this primary care group. This data are numbers for the entire
provider group and are broken down by individual provider. This same data set was requested
approximately two weeks after the last educational intervention. A comparison of the
prescribing of both antibiotics and probiotics using descriptive statistics was done.
The data gathered from the questionnaire was analyzed by both descriptive statistics and
a paired t-test. A paired t-test was utilized because the survey was identified by the provider
name. The raw data with the name was only be seen by the researcher. The paired t-test was
analyzed using IBM SPSS Statistics 20 software. The descriptive statistics were used to
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compare the different provider groups, MD and NP, to see if there are differences in attitude and
knowledge after the educational intervention and presentation of the clinical practice protocol.
The PA information was only used in the summary data and was not compared to the other
providers since there a small number of PA participants (n=4).
Barrier to Project Implementation
This study is only looking at provider attitudes, knowledge and prescribing habits. One
drawback of this study is the outcome of diarrhea in the patients was not determined. The
questionnaire is only 4 questions long and this should not be a burden. The educational
intervention was delivered in person. It is anticipated that due to the suggestion of a practice
change by an NP to a largely MD group may create some resistance of implementation of this
practice protocol.
The MDs did not voice any resistance to a practice change suggested by an NP. This was
a barrier that was anticipated but was not encountered during the study. The response was
positive from all the MDs. I felt more resistance from the NPs and PAs and had difficulty
getting them to stay and listen to the educational program. It is unknown as to why the NPs and
PAs were resistant; this could be a false perception by the researcher. The most challenging
barrier was the reduced time line to provide the educational intervention to the providers. The
scheduling was difficult due to provider meetings being only once a month. While the medical
directors in each office were contacted directly, often it was the practice manager who scheduled
the meeting. The practice manager was not necessarily aware of the project and often it took
several emails to schedule the intervention.
Budgeting and Cost
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The cost of this project was very minimal. Cost of the project is the time of the
researcher. The request for the EMR data carried no cost. The questionnaire was created and
printed on the researcher’s personal computer. The expense of obtaining IBM SPSS Statistics 20
software was less than expected, $44.94. However, the cost of gas to drive to each office was
much greater than anticipated. The total mileage was 263 miles at 55.5 cents a mile comes to a
total of $145.97. The original budge was approximately $300.00 this project came under budget
by $109.09. These expenses were absorbed by the researcher.
IRB Approval and Ethical Considerations
IRB approval from the University of Massachusetts, Amherst, was required as an
expedited application as no patient identifying information is being collected. The use of the
EMR information is purely numerical, how many antibiotics prescribed and how many
probiotics are prescribed at the same time. The knowledge survey asked for a name and minimal
demographic information on the providers. Names and demographic information were kept
confidential. The results of the pre and post intervention survey have only been viewed by the
researcher and researcher’s primary advisor. The benefit to the providers was the participation in
and educational offering on probiotics and the distribution of an evidence based practice
protocol.
The University of Massachusetts IRB granted approval on March 1, 2012. Approval for
the provider group was granted by Dr. Kent Stahl on February 13, 2012.
Time Line
Task

Deadline

36

USE OF PROBIOTICS TO PREVENT ANTIBIOTIC ASSOCIATED DIARRHEA
Capstone project approval

December 20, 2011

UMass IRB approval

December 30, 2011

Hartford Medical Group (HMG) IRB approval

December 30, 2011

Contact each medical office at HMG to set up

January 5, 2012

the educational session
Contact with HMG IT Department to request

January 10, 2012

EMR data for the previous 7 days
Finalize the providers data set and analyze

January 10, 2012

Analyze the questionnaire

January 20, 2012

Educational sessions with each office to start

January 20, 2012

Educational sessions with each office to

February 15, 2012

conclude
Analyze provider questionnaire

February 20, 2012

Contact with HMG IT Department to request

February 20, 2012

EMR data for the previous 7 days
Analyze and compare EMR data

February 29, 2012

Results
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Data Analysis
EMR Findings
The analysis of the information collected from the Allscripts® EMR regarding current
prescribing habits provides a snapshot of current clinical practice of the providers in this primary
care group. The information provided showed that 71 providers were listed as prescribers in this
data set. In the first week of the data collection 764 antibiotics were prescribed in the one week
period between the dates of February 5, 2012 to February 11, 2012. There were 4477 patient
visit for these same 71 providers during this same time frame. This would be a prescribing rate
for this group of 171 antibiotics per 1000 patient visits. Of the 71 providers prescribing
antibiotics only two providers recorded recommending probiotics to five different patients. Both
of these providers were NPs. This translates to five patients who have a probiotics recorded in
the EMR at the same time as an antibiotic. For the period of April 22, 2012 to April 28, 2012
there were 73 providers prescribing and 504 antibiotics prescribed. Three providers prescribed
probiotics to three different patients. These three providers were two MDs and one NP, the NP
was a different NP from the two NP prescribers in the first data set. This is a 50% increase in the
number of providers prescribing probiotics but a decrease in the number of patients. This may
be explained by the decrease in the number of antibiotics prescribed during the second time
frame.
Comparison of Prescribing Habits of MDs and NPs
A comparison of the prescribing habits of MD, NP and PA was also analyzed. For the
week of February 5, 2012 to February 11, 2012, the prescribing habits are not different across the
provider types (F=2.217, p=0.110). For the week of April 22, 2012 to April 28, 2012, the
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prescribing habits across the provider types are had no significant difference (F=1.268, p=0.261).
This is consistent with national prescribing habits between provider types (Gonzales, Barrett,
Crane & Steiner, 1998, Ladd, 2005, & Roumie, et. al, 2005)
Provider Attitude toward Probiotics
The data reveals that 21 of the 27 (77.8 %) providers have advised probiotics prior to
attending the educational presentation. After the presentation 24 (88.9%) providers stated that
probiotics would be advised. Only two of the providers felt that probiotics may be valid but that
they would not advise the use of these supplements. None of the providers chose the option, “I
know of no reason to advise patients to take probiotics.”
Provider Knowledge of Probiotics
Knowledge questions two, three and four were combined to create a knowledge score.
The percent of providers aware of probiotic use pretest was 58.02% the posttest percentage
increased to 75.54%, see Table 8. This is a 17.52% increase in probiotic knowledge after the
educational intervention. There was a significant difference (p=0.001) in the scores for preknowledge (M = 4.92, SD = 1.521) and post knowledge (M = 3.81, SD = 1.021). The correlation
between the two measures was 0.274 (p=0.176).
Difference between MD and NP in Attitude and Knowledge
The paired t-test showed no significant difference in attitude towards the use of probiotics
between the MDs (pretest: n=15, mean=2.87, SD=0.352 and posttest: n=15, mean=2.87,
SD=0.352) and NPs (pretest: n=8, mean 2.88, SD=3.54 and posttest: n=8, mean=3.00, SD=0.000)
For question one the pretest showed equal variances (F=0.012, p=0.957) and the posttest for
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question one also showed equal variances, (F=6.278, p=0.164). The knowledge score showed a
significant difference between MDs pretest (n=15, mean 5.2667, SD=1.16292) and NPs pretest
(n=8, mean=3.7500, SD=1.03510). Again, there was a significant difference between MD
posttest (n=15, mean=4.2000, SD=1.08233) and NP posttest (n=8, mean=3.0000, SD=0.0000).
The paired t-test for the pretest knowledge score also showed a significant difference between
MDs and NPs (F(21)=0.034, p=0.006). The paired t-test for the posttest knowledge score
showed a significant difference between the MDs and NPs scores (F(21)=59.345, p=0.005).
Discussion
The purpose of this study was to evaluate the attitude and knowledge regarding the use of
probiotics to prevent AAD in the outpatient adult setting. The results show that MDs and NPs
have a positive attitude towards the use of probiotics. They have advised their patients on the
value of these supplements. The results also show that MDs and NPs increased their knowledge
of probiotics due to the educational intervention. However, it was found that NPs had a greater
increase in their knowledge scores as compared to MDs.
The goal of introducing an evidence based protocol was accomplished. The protocol was
presented to the providers and they were encouraged to use it. There was positive feedback
during the educational sessions for the protocol. The providers indicated that the handout that
described the protocol was helpful especially since it contained specific recommendations on
dosing and length of treatment. Dr. Kent Stahl supported the use of this protocol within our
primary care and urgent care practice.
The third purpose of this study was to evaluate the providers’ use of probiotics as
documented in the EMR. The initial data revealed that while providers have a positive attitude
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towards probiotics and recommend probiotics they are not recording this in the EMR. After the
education intervention the probiotics that were recorded in the EMR increased by 50%. There
were two different prescribing providers both NPs who prescribed probiotics prior to the
educational intervention. After the educational intervention there were three different providers
that prescribed probiotics, two MDs and one NP. The extra step of recording the probiotic in the
EMR is problematic. It is actually five extra mouse clicks to record another medication in the
EMR, many providers feel overwhelmed with the amount of information they are required to
record already. This has been a common complaint voiced at provider meetings within this
group. In future studies with this group, if the providers could be incentivized to record the
probiotics this might improve recording outcomes. If the providers could be shown a short cut
within the EMR system that decreased the amount of mouse clicks to record this
recommendation this might also improve the recording of probiotic recommendations.
When the knowledge scores were evaluated NPs showed a greater beginning knowledge
of probiotic use as compared to MD. The NPs also increased their knowledge to a greater degree
than MDs in the posttest.
The data also supported the assertion that there is no difference in the prescribing habits
of MDs and NPs. This can be looked at two different ways. As a negative it could be interpreted
as NPs should prescribe fewer antibiotics because they should be encouraging more self care
interventions and utilize an antibiotic as the last resort. As a positive it supports the notion that
NP practice is no different than MD practice. This group’s antibiotic prescribing habits of 171
per 1000 is well below the national average of 302-304 per 1000 reported by Roumie, et al.,
(2005).
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The goals of this project were not all met. The project fell short on the goal of 50%
participation from the 70 providers’ eligible, only 38% were recruited. This was due to the late
approval from the IRB. The evidence-based protocol for the use of probiotics to prevent AAD
was created and presented in the adult outpatient setting. The protocol appears to have been well
received by the providers who attended the educational interventions. The interventions went
smoothly and care was taken to present the information in the same way at each office. The goal
of documenting and analyzing current antibiotic and probiotic prescribing habits was met.
However, since probiotics are over the counter supplements this is really measuring the providers
documentation of the probiotic in the EMR. There is no way to know if the patient actually
followed this recommendation.
A limitation of this study were that the small number of providers that participated in the
educational intervention. This study looked at the prescribing providers of a primary care and
urgent care group; these results cannot be generalized to other provider populations. This study
will be continued until the participants’ number over 50. There are already three more offices
scheduled to have the educational program in May and June.
In conclusion this study showed that primary care providers have a positive attitude
towards the use of probiotics. It also showed that providers increased their knowledge of
probiotic use as a result of an educational intervention. The actual prescribing rate of probiotics
as recorded in the EMR was slightly higher after the educational intervention; however due to
the small number of participants it may not be attributable to the educational intervention. It is
proposed that actual recommendation of probiotics is higher but it is just not recorded in the
EMR.
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Future Directions
Further research is needed on the use of probiotics. The implementation of the proposed
protocol could be one future study. Further research is needed on both the dosing of probiotics
as well as the timing of probiotics. There is little research confirming the dosing of probiotics at
five billion colony forming units. There is also little research specifically focused on when the
probiotic should be given in relation to the antibiotic. The patients in the outpatient adult setting
have not been well represented in current research. A qualitative study that addresses the patient
experience with the use of probiotics would advance the body of literature for adults.
The abstract for this paper was submitted to American Association of Nurse Practitioners
Foundation for a grant to continue research in this area. The grant is for best practices in the use
of nutritional supplements. The dealing for submission is April 30, 2012 and the award
presentation will be the 27th Annual American Association of Nurse Practitioners National
Conference in Orlando, Florida.
Plans for Dissemination
The pathophysiology and the demonstration quality initiative that inspired this project
have already been presented twice. The quality initiative has been presented in poster form at
three different nursing conferences: the national DNP conference in San Diego California
September 2010, Connecticut Advanced Practice Registered Nurse Society’s annual conference
May 2011, and CT Nursing Research Alliance Conference on 10/14/11. The poster received
third place at the CT Nursing Research Alliance Conference and honorable mention at the
Connecticut Advanced Practice Registered Nurse Society’s conference. The pathophysiology
and the quality initiative were presented at this year’s Connecticut Advanced Practice Registered
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Nurse Society’s annual conference as a session choice. The results of this project are to be
presented at Windham Community Memorial Hospital at Grand Rounds, to be scheduled in June.
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Table 1
Percent of Providers by Title
Professional Title

Frequency

Percent

MD

15

55.6%

NP

8

29.6%

PA

4

14.8%

27

100%

Total

55
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Table 2
Percent of Providers by Gender

Total

Gender

Frequency

Percent

Male

10

37.0%

Female

17

63.0%

27

100%

56
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Table 3
Percent of Providers by Age
Age Range

Frequency

Percent

20-29

0

0%

30-39

7

25.9%

40-49

8

29.6%

50-59

7

25.9%

60-69

3

11.1%

70+

0

0%

Missing

2

7.4%

27

100%

Total

57

USE OF PROBIOTICS TO PREVENT ANTIBIOTIC ASSOCIATED DIARRHEA
Table 4
Percent of Providers by Educational Preparation
Educational Level

Frequency

Percent

Certificate

1

3.7%

Masters

10

37.0%

MD

15

55.6%

DNP

0

00.0%

Missing

1

3.7%

27

100%

Total

58

USE OF PROBIOTICS TO PREVENT ANTIBIOTIC ASSOCIATED DIARRHEA

59

Table 5
Question 1 Responses
Questions 1

Pre-Test

Post-Test

0

0

5

2

21

24

Missing

1

1

Total

27

27

Which of the following statement apply to your advice to
patient regarding probiotics:
a. I know of no reason to advise patients to take
probiotics
b. Probiotic usage may be valid but I have not
advised my patients on these supplements
c. I have advised patients on the value of taking
probiotics
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Table 6
Question 2 Responses
Questions 2

Pre-Test

Post-Test

Yes

25

26

No

0

0

Don’t know

1

0

Missing

1

1

Total

27

27

Probiotics decrease the incidence of diarrhea
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Table 7
Question 3 Responses

Questions 3

Pre-Test

Post-Test

Yes

15

20

No

4

4

Don’t know

7

2

Missing

1

1

Total

27

27

Probiotics decrease the risk of vaginitis due to yeast
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Table 8
Question 4 Responses

Questions 4

Pre-Test

Post-Test

Yes

7

16

No

8

7

Don’t know

11

3

Missing

1

1

Total

27

27

Probiotics give a boost to immunity
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Table 9
Combined Knowledge Score

Questions 2, 3, & 4

Pre-Test

Pre-Test

Post-Test

Percent

2. Probiotics decrease the incidence of

Post-Test
Percent

diarrhea
3. Probiotics decrease the risk of vaginitis
due to yeast
4. Probiotics give a boost to immunity
Yes

47

58.02%

62

75.54%

No

12

14.81%

11

13.58%

Don’t know

19

23.46%

5

6.17%

Missing

3

3.7%

3

3.7%

Total

81

100%

81

100%

Percent columns may not equal 100 due to rounding.

USE OF PROBIOTICS TO PREVENT ANTIBIOTIC ASSOCIATED DIARRHEA
Appendix 1: Evidence-Based Protocol Describing the Use of Probiotics in the Adult
Outpatient Population.
When an antibiotic is prescribed for any condition the following guidelines can be taken into
consideration when also prescribing a probiotic.
Strain: Lactobacillus, S. boulardii, Bifdobacterium are the most studied probiotics. (Avadhani &
Miley, 2011, Cremonini, et al, 2002, Edwards-Marshall, 2011, Hickson, et al, 2007, Hunter,
2004, Rohde, Bartolini, & Jones, 2009, Santosa, Farnworth, & Jones, 2006, Vrabie & Aberra,
2009, & Weichselbaum, 2009, Williams, 2010) .Culturelle, Align, Florastor or generic
equivalent will be recommended since these OTC products contain one of the above mentioned
probiotics.
Dose: 1 million to 100 billion CFUs QD to BID. (Avadhani & Miley, 2011, Cremonini, et al,
2002, Fox & Dang, 2004, Hickson, et al, 2007, Rohde, Bartolini, & Jones, 20091 & Santosa,
Farnworth, & Jones, 2006)
Dose Timing: At least 2 hours from the dose of antibiotic. (Williams, 2010)
Therapy Duration: At least during the antibiotic treatment course and up to 6 weeks after
completion. The average is 7-14 days. (Edwards-Marshall, 2011, Cremonini, et al, 2002 &
Vrabie & Aberra, 2009)
Contraindications: S. boulardii should not be given with antifungals. (Williams, 2010)
Safety: Probiotics are generally considered safe. (Hickson, et al, 2007, Rulis, 2002
&Venugopalan, Shriner, Wong-Beringer, 2010)
Risk Factors for Sepsis: Immune compromised individuals (including debilitated state or
malignancy) and Premature Infants are at risk for sepsis. Minor risk factors include: central
venous catheter, impaired intestinal epithelial barrier, administering probiotic by jejunostomy,
broad spectrum antibiotic to which the probiotic is resistant, probiotics with high mucosal
adhesions, use of Lactobacillius and cardiac valvular disease. The presence of one major risk
factor and two or more minor risk factors should caution the use of a probiotic (Boyle, RobinsBrowne & Tang, 2006)
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Appendix 2: Survey Questions:
1. Which of the following statements apply to your advice to patients regarding probiotics:
a) I know of no reason to advise patient to take probiotics.
b) Probiotic usage may be valid but I have not advised patients on these supplements
c) I have advised patient on the value of taking probiotics

2. Probiotics decrease the incidence of diarrhea:
Yes

No

Don’t Know

3. Probiotics decrease the risk of vaginitis due to yeast:
Yes

No

Don’t Know

4. Probiotics give a boost to host immunity
Yes

No

Don’t Know

Used with permission.
Nichols, J. A. A., Grob, P. R., & Roche, N. (2005). A web questionnaire to determine the advice
general practitioners give on probiotics. Journal of Nutritional & Environmental
Medicine, 15(4) 212-222. doi:10.1080/13590840600692980.
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Appendix 3
PEMR Analytics Report Request
Name:

Phone:

Purpose of this report:

Criteria:(please check all that apply and enter specific information in space provided)
Organization Name:
Provider Names
Site Names
Diagnosis
Order Names
Result Names
Medication Names
Appointment Types
Task Types
Date/Date Range
Other
Include: Deceased

Deactivated

Report Needed by:

Priority

Desired Output: (Ex: Pt full name, MRN, DOB, Phone, A1c, Provider, Date of last arrived appt)
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Appendix 4: Stakeholder Letter
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Appendix 5: Probiotic Handout for Patients
What are probiotics?
Probiotics are bacteria found naturally in your large intestine. By taking probiotics you
maintain or restore the balance of bacteria normally found in your body.
Why is my provider recommending I take a probiotic?
One of the side effects of antibiotics is diarrhea. This is because antibiotics kill the
infection you are being treated for as well as the normal bacteria found in your intestine. When
the normal bacteria are also wiped out diarrhea can occur. The probiotics help to maintain the
normal bacteria so you don’t get diarrhea.
Where can I get probiotics?
Most of the pharmacies and grocery stores carry both name brand probiotics and store
brand probiotics, either one is fine. You may also look for probiotics at natural foods stores.
How much do they cost?
The cost is $10 to $40 dollars depending on the brand and size of the bottle.
How much should I take?
Your provider should tell you to either follow the package instructions or give you
instructions on how many pills to take. 5 billion CFU are recommended but you should ask your
provider how much you should take. Your provider should discuss how long you should
continue the probiotic, usually at least as long as you are on the antibiotic.
When should I take them?
They should not be taken at the same time as the antibiotic but separated by 2 hours from
your antibiotic dose.
What are the side effects of probiotics?
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Probiotics are accepted as safe by the FDA. However, some people may experience gas
cramps and gas bloating from probiotics. If this happens tell your provider. This will often
happen if you take more than the recommended dose.

69

USE OF PROBIOTICS TO PREVENT ANTIBIOTIC ASSOCIATED DIARRHEA
Appendix 6: Email from Dr. John Nichols and Dr. Paul Grob
----- Original Message ----From: John Nichols
To: Liz Visone

Sent: Wednesday, August 10, 2011 4:40 AM
Subject: Fw: Fw: Web Questionnaire on Probiotics

Dear Liz,
My co-author has confirmed that you can use our q'aire in any way you wsh (see below).
Good luck.
John
----- Original Message ----From: PAUL GROB
To: John Nichols

Sent: Wednesday, August 10, 2011 8:24 AM
Subject: Re: Fw: Web Questionnaire on Probiotics
hi fine
paul
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--- On Fri, 5/8/11, John Nichols <drjaan@ntlworld.com> wrote:

From: John Nichols <drjaan@ntlworld.com>
Subject: Fw: Web Questionnaire on Probiotics
To: "Paul Grob" <paul.grob1@btinternet.com>
Date: Friday, 5 August, 2011, 22:06
Dear Paul,
This American nurse practitioner would like to use part of our questionnaire. I have no problem
with this. Is it OK by you? I will try to find out more about her project.
Best wishes.
John
----- Original Message ----From: Liz Visone
To: drjaan@ntlworld.com

Sent: Thursday, July 28, 2011 2:04 AM
Subject: Web Questionnaire on Probiotics

Dear Dr. Nichols,
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I am a doctoral student in the United States working my dissertation/capstone project for
graduation. I would like to use parts of your questionnaire in my project. I found the first four
questions in your article appropriate for my project as a pre and post test. I will be suggesting a
practice guideline for use in an outpatient primary care practice.
I would like to obtain permission to use your questions in my study, how would I go about doing
this. Thank you for your help.
Elizabeth Visone, RN, MSN, APRN-BC
Nurse Practitioner
Doctoral Student
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Appendix 7: Educational Intervention

The Use of Probiotics to Prevent Antibiotic
Associated Diarrhea:
Current Primary Care Practice and
Introduction of an Evidence Based Practice
Protocol

Elizabeth MB Visone, MS, RN, APRN-BC
DNP Candidate

School of Nursing
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Learning Objectives
 Understanding translational research
 Understanding normal gut ecology
 Understanding the effect antibiotics have on
normal gut ecology
 Review of evidence of prophylactic probiotics
to prevent antibiotic associated diarrhea
 Proposed evidence based protocol for the use
of probiotics to prevent antibiotic associated
diarrhea
School of Nursing
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Translational Research
 This is research that moves the “bench
experiment” to the bedside
 Taking current research and quickly moving it to
the bedside
 Understanding that while rigor is important,
there are many more variables at the bedside
and many cannot be controlled
 How does laboratory knowledge translate with
real patients under real life conditions

School of Nursing
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Normal Gut Ecology
 The gut contain 300-500 different bacterial
species
 30-40 species comprise the majority of bacteria
 Most of the gut bacteria is found in the colon

School of Nursing
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Normal Gut Ecology
 pH in the stomach and small intestine prohibit
bacterial colonization
 Unless you count Helicobacter pylori
 The entire community of bacteria in the gut has
yet to be described

School of Nursing
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Normal Gut Ecology
 Humans are born with a sterile gut
 Gut bacteria is populated during the birth
process and neonatal period
 The initial ecology of the gut as an infant dictates
the ecology as an adult

School of Nursing
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Normal Gut Ecology
 The healthiest gut ecology is conferred by a
vaginal birth and a breast fed infant
 Humans have a unique and stable gut ecology
 Human gut bacterial flora is like a finger print,
no two people have the same community
members in the same concentration

School of Nursing
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Normal Gut Ecology
anaerobic bacteria outnumber aerobic bacteria by a factor of
1:10









Anaerobes
Bacteroides
Bifidobacterium
Eubacterium
Clostridium
Peptococcus
Peptostreptococcus
Ruminococcus

School of Nursing








Aerobes
Escherichia
Enterobacter
Enterococcus
Klebsiella
Lactobacillus
Proteus
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Normal Gut Ecology
Functions of Gut Microflora:

 Metabolic
 Trophic
 Protective

School of Nursing
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Normal Gut Ecology

Metabolic
 Fermentation
 Mucous Production
 Salvage of Energy

School of Nursing
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Normal Gut Ecology

Trophic
 Epithelial Cell Growth & Developement
 Host Immunity

School of Nursing
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Normal Gut Ecology

Protective
 The intestine has the highest concentration of
immunocompetent cells in the body
 Interface between the body and the external
environment
 Ecological communities of bacteria in the gut are a
defense against invasion of exogenous microbes
and thus prevent infection
School of Nursing
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The Effect of Antibiotics on Gut Ecology
Antibiotics:
 Select for resistant organisms
 Inhibit susceptible organisms

School of Nursing
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The Effect of Antibiotics on Gut Ecology
Alterations in Gut Mucosa:
 Changes in fermentation of carbohydrates and creation
of mucous will change nutrient absorption ability of the
host and inhibit immunological functions
 Abdominal pain most likely caused by diarrhea, bloating,
and flatulence
 Selection of resistant organisms for continued growth
produces an imbalance in the microflora
School of Nursing
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The Effect of Antibiotics on Gut Ecology

Broad spectrum antibiotics are most
often implicated

However
Any Antibiotic can cause AAD
School of Nursing
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The Effect of Probiotics on Gut Ecology

A probiotic is defined by the World
Health Organization as “Live
microorganisms which when
administered in adequate amounts
confer a health benefit on the
host.”
(World Health Organization, 2001)

School of Nursing
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L1

The Effect of Probiotics on Gut Ecology
 Support the native bacteria of the gut
 Preservation of the native bacterial community
 Encourage mucous production
 Encourages the immunity functions of the native
bacteria

School of Nursing
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DEFINITION OF AAD

Antibiotic associated diarrhea
(AAD) is the self limited diarrhea
that occurs during or following a
course of antibiotics

School of Nursing
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Incidence of AAD
 5-30% of adults prescribed an antibiotic
 301.4 out of 1000 adults were prescribed an
antibiotic in the year 2002
 Resulting in 29 million adults in the US with
AAD in the year 2002

School of Nursing
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Incidence of AAD

 Current treatment for AAD is to stop the offending
antibiotic

 Antibiotic treatment is necessary

 Prevention of AAD is a better choice

School of Nursing
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Evidence for the use of Probiotics to
Prevent AAD
No evidence based clinical guidelines available
for the prevention in AAD in adults
Evidence based clinical guidelines are available
for the pediatric population
7 meta-analyses and 1 RCT evaluated the
efficacy of probiotics to prevent AAD

School of Nursing
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META-ANALYSIS: Avadhani & Miley (2011)
 Consists of 8 RCT evaluating probiotic efficacy in the
prevention of AAD
 Includes 2 RCT that report negative results
 Focus was prevention of AAD & C. difficile in
hospitalized adults
 Report a Relative Risk Ratio of 56%
 Conclude concurrent use of probiotics and antibiotics
as effective in preventing AAD in the hospitalized
adult patient

School of Nursing
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META-ANALYSIS: Cremonini, et al (2002)
 Consists of 7 RCT evaluating probiotic efficacy in the
prevention of AAD
 Includes 1 RCT that report negative results
 Focus was prevention of AAD in an age range of 2
weeks to elderly
 Investigated probiotic monotherapy using
Lactobacillus GG or S. Boulardii
 Conclude probiotics reduce the risk of AAD

School of Nursing
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META-ANALYSIS: D’Souza, Rajkumar,
Cooke, & Bullpitt (2002)
 Consists of 9 RCT evaluating probiotic efficacy in the
prevention & treatment of AAD
 S. boulardii, lactobacilli or enterococci were
evaluated
 Focus was prevention of AAD in both adult and
pediatric populations
 Relative Risk of 37%
 Conclude probiotics prevent AAD but do not treat
AAD

School of Nursing
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META-ANALYSIS: Kale-Pradhan, Jassal &
Wilhelm (2010)
 Consists of 10 RCT evaluating probiotic monotherapy
efficacy in the prevention of AAD
 Lactobacillus was evaluated
 Focus was prevention of AAD in both adult &
pediatric populations, results were reported
separately
 Relative Risk of 24%
 Conclude probiotics prevent AAD in the adult
population

School of Nursing
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META-ANALYSIS: McFarland (2010)
 Systemic review & meta-analysis of S. boulardii in
adults
 10 RCT using S. boulardii as monotherapy
 Focus was prevention of AAD in both adult &
pediatric populations, results were reported
separately
 Relative Risk of 47%
 Conclude S. boulardii prevents AAD in the adult
population both in the inpatient & outpatient setting

School of Nursing
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META-ANALYSIS: Sazawal, et al (2006)
 Meta-analysis evaluated 16 RCT focusing on the use
of probiotics in all types of acute diarrhea
 All RCT in the analysis were masked & placebo
controlled
 Focus was prevention of acute diarrhea in both adult
& pediatric populations
 Relative Risk reduction of 52%
 Conclusion: of all types of acute diarrhea, probiotics
have the greatest effect on preventing AAD

School of Nursing
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META-ANALYSIS: Szajewska & Mrukowicz
(2005)
 Meta-analysis evaluated 5 RCT focusing on the use
of S. boulardii for the prevention of AAD

 Includes both adult & pediatric populations

 Relative Risk reduction of 43%

 Conclusion: S. boulardii reduces the risk of AAD

School of Nursing
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RCT: Armuzzi, et al (2001)
 RCT with outpatient adults given probiotics during a
specific antibiotic treatment
 Randomized 60 healthy asymptomatic H. pylori
positive adults to probiotic or placebo
 H. pylori treatment: raberprazole, clarithromycin, &
tinidazole all BID
 Lactobacillus GG (6x109 CFU) or placebo BID for
14d; 1-1/2 hours after the antibiotic administration
 All the side effects of antibiotic use were included in
the study, only diarrhea was significant (p=0.026)
School of Nursing
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RCT: Armuzzi, et al (2001),

continued

 Diarrhea rates reported: placebo 26.6% versus
probiotic 3.3%
 Side effects were self reported and all diarrhea was
reported as mild for all participants
 Of note all the study participants were a convenience
sample of medical personnel (MD, RN, biologists or
administrators)

School of Nursing
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Study

Results

Avadhani & Miley (2011)

concurrent use of probiotics and antibiotics as effective
in preventing AAD in the hospitalized adult patient

Cremonini, et al (2002)

Conclude probiotics reduce the risk of AAD

D’Souza, Rajkumar, Cooke,
& Bullpitt (2002)

Conclude probiotics prevent AAD but do not treat AAD

Kale-Pradhan, Jassal &
Wilhelm (2010)

Conclude probiotics prevent AAD in the adult population

McFarland (2010)

Conclude S. boulardii prevents AAD in the adult
population both in the inpatient & outpatient setting

Sazawal, et al (2006)

Conclusion: of all types of acute diarrhea, probiotics
have the greatest effect on preventing AAD

Szajewska & Mrukowicz
(2005)

Conclusion: S. boulardii reduces the risk of AAD

Armuzzi, et al (2001)

All the side effects of antibiotic use were included in the
study, only diarrhea was significant (p=0.026)

School of Nursing
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Conclusions
 All 7 meta-analyses and 1 RCT agree that AAD is
prevented when probiotics are included in the
treatment plan
 There is a wide variety of probiotics, diagnoses,
antibiotics, patient populations and settings
reported
 There is an overlap of studies across the metaanalyses

School of Nursing
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Conclusions

While there is no agreement on
the best probiotic or the optimal
dose there are some guidelines
that can be gleaned from the
literature

School of Nursing
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Introduction of the Evidence-Based Protocol

Evidence-Based Protocol
describing The Use of Probiotics
in the Adult Outpatient
Population
When an antibiotic is prescribed for any condition
the following guidelines can be taken into
consideration when prescribing a probiotic for
AAD prevention.

School of Nursing
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Introduction of the Evidence-Based Protocol

Strain
Lactobacillus, Bifdobacterium, S. boulardii are
the most studied probiotics.
(Avadhani & Miley, 2011; Cremonini, et al, 2002; Edwards-Marshall, 2011; Hickson,
et al, 2007; Hunter, 2004; Rohde, Bartolini, & Jones, 2009; Santosa, Farnworth, &
Jones, 2006; Vrabie & Aberra, 2009; Weichselbaum, 2009; Williams, 2010)

Culturelle, Align, Florastor or generic equivalent
can be recommended since these OTC products
contain one of the above mentioned probiotics.

School of Nursing
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Introduction of the Evidence-Based Protocol

Dose
1 million to 100 billion CFUs QD to BID.
(Avadhani & Miley, 2011; Cremonini, et al, 2002; Fox & Dang, 2004;
Hickson, et al, 2007; Rohde, Bartolini, & Jones, 2009; Santosa,
Farnworth, & Jones, 2006; Wallace, 2009)

School of Nursing
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Introduction of the Evidence-Based Protocol

Dose Timing

At least 2 hours from the dose of antibiotic. This
can be either before the antibiotic or after the
antibiotic dose.
(Williams, 2010)

School of Nursing
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Introduction of the Evidence-Based Protocol

Therapy Duration
At least during the antibiotic treatment course
and up to 6 weeks after completion. The
average is 7-14 days.
(Edwards-Marshall, 2011; Cremonini, et al, 2002; Vrabie & Aberra, 2009)

School of Nursing
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Introduction of the Evidence-Based Protocol

Contraindications

S. boulardii should not be given with antifungals.
(Williams, 2010)

School of Nursing
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Introduction of the Evidence-Based Protocol

Safety
Probiotics are generally considered safe.
(Hickson, et al, 2007; Rulis, 2002; Venugopalan, Shriner, & WongBeringer, 2010)

School of Nursing
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Introduction of the Evidence-Based Protocol

Risk Factors for Sepsis
 Major risk factors include: immune compromised
individuals (including debilitated state or malignancy)
and premature infants are at risk for sepsis
 Minor risk factors include: central venous catheter,
impaired intestinal epithelial barrier, administering
probiotic by jejunostomy, broad spectrum antibiotic
to which the probiotic is resistant, probiotics with
high mucosal adhesions, use of Lactobacillius and
cardiac valvular disease
 The presence of one major risk factor and two or
more minor risk factors should caution the use of a
probiotic
School of Nursing
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How to document Probiotics in Allscripts®
 When you are picking the antibiotic in Allscripts®
medication section, you can also document the
recommendation of a probiotic. You can
document just Probiotic or you can document a
specific OTC probiotic.
 If you search the term “probiotic” in the
medication section the following screen shot is
returned. You can select your favorites or just
use the generic Probiotic.

School of Nursing
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Screen Shot of Probiotic Search
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